Immune clues in the ICU: can blood tests predict who will survive?

NCT ID NCT07345169

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 540 adults admitted to the intensive care unit (ICU) to see how their immune and inflammatory responses relate to their recovery. Researchers will collect extra blood samples at several time points over one year to measure immune cells and inflammation markers. The goal is to build models that predict survival and infections, which could eventually help doctors tailor treatments for critically ill patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict which ICU patients are at higher risk of complications or death, leading to more personalized care.
What could go wrong: This is an observational study, not a treatment trial. It will not directly improve patient outcomes, and the findings may not apply to all ICU populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness infectious disease with sepsis Inflammation nosocomial infection Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICAL ILLNESS CRITICAL ILLNESS REQUIRING INTENSIVE CARE - ACUTE BRAIN INJURY CRITICAL ILLNESS REQUIRING INTENSIVE CARE - MAJOR SURGERY CRITICAL ILLNESS REQUIRING INTENSIVE CARE - POLYTRAUMA CRITICAL ILLNESS REQUIRING INTENSIVE CARE - SEPSIS INTENSIVE CARE PATIENTS

Contacts and locations

Locations

AP-HP Laribosière Hospital, Anesthesia and Critical Care Departement
RECRUITING

Paris, 75010, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.